HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Dynavax Technologies Corporation (DVAX)
8.67  0.36  (4.33%) 07-03 15:33
Open: 8.31 High: 8.8
Pre.close: 8.31 Low: 8.16
Volume: 4,269,020 Ave vol: 6,343,749
52w High: 9.74 52w Low: 1.8
MA(50): 6.464 MA(200): 5.024
EPS: -1.776 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.dynavax.com
Market Cap (M): 943
Shares Out (M): 109
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Its immuno-oncology portfolio includes development stage products, such as SD-101 and DV281. Dynavax Technologies Corporation has a research collaboration with Clover Biopharmaceuticals; the University of Queensland and the Coalition for Epidemic Preparedness; and Sinovac Biotech Ltd. for the development of a vaccine candidate to prevent coronavirus (COVID-19). Dynavax Technologies Corporation has partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine against COVID-19 infection; and a collaboration with Valneva SE to initiate a vaccine program for the coronavirus, COVID-19.
Technical analysis
Overall: Neutral
MA: Bullish MACD: Bullish
KDJ: Bullish RSI: Bullish
Target 1: 11.38 Target 2: 13.29
Resist 1: 9.74 Resist 2: 11.38
Support 1: 6.87 Support 2: 5.10
Company key metrics
Revenue per Share: 488.9898
Net Income per Share: -2118.7382
Cash per Share: 553.7599
Book Value per Share: 115.1005
Price to Sales: 0.0102
Price to Book Value: 0.0434
Earnings Yield: -424.5968
Dividend Yield: 0
Debt to Equity: 32.6632
Debt to Assets: 0.9703
Financial analysis
Price to Book Value: Neutral
Return on Assets: Neutral
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Neutral
Debt to Equity: Outperform
Stock Charts
Headline news
Sun, 21 Jun 2020
Hedge Funds Never Been Less Bullish On Dynavax Technologies Corporation (DVAX) - Yahoo Finance

Mon, 29 Jun 2020
Stocks To Trade: Dynavax Technologies Corporation (DVAX) Attracting Wallstreet Traders - Invest Million

Mon, 22 Jun 2020
Dynavax Technologies (DVAX) Jumps: Stock Rises 6.6% - Yahoo Finance

Tue, 30 Jun 2020
Moving Average Crossover Alert: Dynavax Technologies - Yahoo Finance

Thu, 02 Jul 2020
Dynavax Technologies Corporation (DVAX) Soars 4.33% on July 02 - Equities.com

Fri, 03 Jul 2020
A Little Luck Can Go a Long Way with Dynavax Technologies Corporation (DVAX) as it 5-day change was 5.54% - News Daemon

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.